Precigen (PGEN) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,977.86+0.07%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Precigen Inc (PGEN) Stock Price, Quote, News & History

PGENNASDAQ

Trade with Public

Trade with Public

$7.81

0.212.76%

Last update: Oct 9, 7:58 PM

$7.81

0.212.76%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.60

Close

$7.81

Volume / Avg.

3.38M / 4.98M

Day Range

$7.81 - $7.81

52 Wk Range

2.99 - 8.98

Market Cap

$2.72B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

54

Short Interest

24.36%

Days to Cover

7.38

Recent Precigen, Inc. News

Constellation Brands, Caribou Biosciences And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

U.S. stock futures fell; Constellation Brands dropped 5.1% despite beating estimates, while biotech, mining and other stocks declined premarket.

Avi Kapoor

This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TSEM, PGEN, SPTX, PDFS and CF, setting targets of $300, $12, $46, $60 and $162.

Avi Kapoor

Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.

Avi Kapoor

Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares rose 13% in pre-market trading.

Avi Kapoor

Partner Content

Precigen Gains Advantage As PAPZIMEOS Granted Orphan Drug Exclusivity By FDA; Long-Term Data From Clinical Study Encouraging

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-114.17M

Investing Cash Flow (TTM)

24.14M

Financing Cash Flow (TTM)

92.57M

Free Cash Flow (TTM)

-115.22M

Capital Expenditure (TTM)

-1.06M

Net Change in Cash (TTM)

2.54M

Analyst Trends and Forecast

2

May

2

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.86B

PE Ratio (TTM)

-

PE Ratio (FWD)

17.24

PEG Ratio (TTM)

-

PS Ratio (TTM)

32.91

PB Ratio (TTM)

62.36

Earnings Yield % (TTM)

-14.10%

Earnings Yield % (FWD)

5.80%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.12

Company Debt

Total Debt

$93.88M

LT Debt

$93.88M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$16.33M

Debt to Equity

2.26

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-